Wealthstar Advisors’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,134
Closed -$585K 116
2025
Q4
$585K Buy
6,134
+717
+13% +$70.3K 0.26% 75
2025
Q3
$529K Sell
5,417
-1,421
-21% -$147K 0.21% 91
2025
Q2
$734K Buy
6,838
+830
+14% +$84K 0.28% 65
2025
Q1
$606K Buy
6,008
+419
+7% +$42.2K 0.28% 79
2024
Q4
$499K Buy
+5,589
New +$492K 0.22% 87
2024
Q2
Sell
-5,930
Closed -$406K 40
2024
Q1
$406K Buy
5,930
+8
+0.1% +$514 0.14% 89
2023
Q4
$342K Buy
+5,922
New +$316K 0.05% 93

Other funds holding BSX

Wealthstar Advisors's BSX Position: Q1 2026 in Review

Wealthstar Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,134 shares — an estimated $585K sold.

Wealthstar Advisors first reported a position in BSX in Q4 2023 and held it in 7 quarters. The position peaked at $734K in Q2 2025. 1,681 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Wealthstar Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Wealthstar Advisors sold 6,134 Boston Scientific shares in Q1 2026, an estimated $585K.
  • Wealthstar Advisors first reported a position in Boston Scientific in Q4 2023 and held it in 7 quarters.
  • Wealthstar Advisors's Boston Scientific position peaked at $734K in Q2 2025.
  • 1,681 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Wealthstar Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.